DalsnaFinance › IPOs › Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. completed its initial public offering on NASDAQ on February 5, 2026, pricing at $18.00 a share.
| Ticker | EIKN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 5, 2026 |
| Offering price | $18.00 |
| Shares offered | 21,177,600 |
| Total raised | $381M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.